Astro2020 Science White Paper: Science at the edges: internal kinematics of globular clusters' external fields

Autor: Bellini, A., Libralato, M., Anderson, J., Bennett, D., Calamida, A., Casertano, S., Fall, S. M., Gaudi, B. S., Guhathakurta, P., Ho, S., Lu, J., Malhotra, S., Melchior, P., Nelan, E., Rhodes, J., Sanderson, R. E., Shao, M., Sohn, S. T., Vesperini, E., van der Marel, R. P.

The outer regions of globular clusters can enable us to answer many fundamental questions concerning issues ranging from the formation and evolution of clusters and their multiple stellar populations to the study of stars near and beyond the hydrogen

Externí odkaz: http://arxiv.org/abs/1903.05085

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.

Autor: Colton H; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Barratt N; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent and Greenwich, Chatham, UK., Hornsby H; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Angyal A; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Grouneva I; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Lindsey BB; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Kearns P; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Barnes E; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Goodyear CS; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Richter A; Clinical Immunology Service, University of Birmingham, Birmingham, UK., Thomas D; The Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, UK., Cook G; National Institute for Health Research, Leeds MIC, University of Leeds, Leeds, UK., McInnes IB; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Willicombe M; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, UK., Siebert S; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Orchard K; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Selby R; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Bowden S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Collini PJ; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK., Pope A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Kirkham A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Kronsteiner B; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Dunachie SJ; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Miller P; British Society of Blood and Marrow Transplantation and Cellular Therapy, Guy's Hospital, London, UK., Clay J; Department of Haematology, St James's University Hospital, Leeds, UK., Hurst E; Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Malladi R; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Kesavan M; Department of Oncology, Cancer and Haematology Centre, Churchill Hospital, Oxford, UK., Kinsella F; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Sanderson R; King's College Hospital NHS Foundation Trust, London, UK., Yong KL; Department of Haematology, Cancer Institute, University College London, London, UK., Rea D; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK., Parry H; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Lim SH; Centre for Cancer Immunology, University of Southampton, Southampton, UK., Snowden JA; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., de Silva TI; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre and the Florey Institute of Infection, University of Sheffield, Sheffield, UK.; Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Dec; Vol. 205 (6), pp. 2206-2218. Date of Electronic Publication: 2024 Nov 17.

Corrigendum to "An update on ICU outcomes in patients after CAR-T therapy: A four-year tertiary UK centre experience" [J Crit Care. 2024 Apr:80:154511].

Autor: Scourfield L; Department of Critical Care, King's College Hospital NHS Foundation Trust, London, United Kingdom; Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom. Electronic address: lily.scourfield@nhs.net., Pirani T; Department of Critical Care, King's College Hospital NHS Foundation Trust, London, United Kingdom., Singh N; Department of Critical Care, King's College Hospital NHS Foundation Trust, London, United Kingdom., Saha R; Department of Critical Care, King's College Hospital NHS Foundation Trust, London, United Kingdom., Kuhnl A; Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom., Sanderson R; Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom., Metaxa V; Department of Critical Care, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Publikováno v: Journal of critical care [J Crit Care] 2024 Oct; Vol. 83, pp. 154836. Date of Electronic Publication: 2024 May 25.

A strategy for modelling heavy-tailed greenhouse gases (GHG) data using the generalised extreme value distribution: Are we overestimating GHG flux using the sample mean?

Autor: Dhanoa, M.S., Louro, A., Cardenas, L.M., Shepherd, A., Sanderson, R., López, S., France, J.

Publikováno v: In Atmospheric Environment 15 September 2020 237